134 related articles for article (PubMed ID: 36623168)
1. Wide Variability in Dysplasia Detection Rate and Adherence to Seattle Protocol and Surveillance Recommendations in Barrett's Esophagus: A Population-Based Analysis Using the GIQuIC National Quality Benchmarking Registry.
Kolb JM; Davis C; Williams JL; Holub J; Shaheen N; Wani S
Am J Gastroenterol; 2023 May; 118(5):900-904. PubMed ID: 36623168
[TBL] [Abstract][Full Text] [Related]
2. Racial Disparities in Adherence to Quality Indicators in Barrett's Esophagus: An Analysis Using the GIQuIC National Benchmarking Registry.
Jones B; Williams JL; Komanduri S; Muthusamy VR; Shaheen NJ; Wani S
Am J Gastroenterol; 2021 Jun; 116(6):1201-1210. PubMed ID: 33767105
[TBL] [Abstract][Full Text] [Related]
3. Quality indicators in Barrett's endoscopy: Best is yet to come.
Inoue M; Ragunath K
Dig Endosc; 2024 Mar; 36(3):265-273. PubMed ID: 37525901
[TBL] [Abstract][Full Text] [Related]
4. Significant Reduction in the Diagnosis of Barrett's Esophagus and Related Dysplasia During the COVID-19 Pandemic.
Pokala SK; Williams JL; Holub JL; Calderwood AH; Dominitz JA; Iyer PG; Shaheen NJ; Wani S
Am J Gastroenterol; 2024 Feb; 119(2):251-261. PubMed ID: 37782262
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
Wani S; Rubenstein JH; Vieth M; Bergman J
Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
[TBL] [Abstract][Full Text] [Related]
6. Diagnosing dysplasia in Barrett's oesophagus still requires Seattle protocol biopsy in the era of modern video endoscopy: results from a tertiary centre Barrett's dysplasia database.
Nachiappan A; Ragunath K; Card T; Kaye P
Scand J Gastroenterol; 2020 Jan; 55(1):9-13. PubMed ID: 31880176
[No Abstract] [Full Text] [Related]
7. Dedicated Barrett's surveillance sessions managed by trained endoscopists improve dysplasia detection rate.
Ooi J; Wilson P; Walker G; Blaker P; DeMartino S; O'Donohue J; Reffitt D; Lanaspre E; Chang F; Meenan J; Dunn JM
Endoscopy; 2017 Jun; 49(6):524-528. PubMed ID: 28399610
[No Abstract] [Full Text] [Related]
8. Endoscopists systematically undersample patients with long-segment Barrett's esophagus: an analysis of biopsy sampling practices from a quality improvement registry.
Wani S; Williams JL; Komanduri S; Muthusamy VR; Shaheen NJ
Gastrointest Endosc; 2019 Nov; 90(5):732-741.e3. PubMed ID: 31085185
[TBL] [Abstract][Full Text] [Related]
9. Surveillance in Barrett's esophagus: an audit of practice.
Ajumobi A; Bahjri K; Jackson C; Griffin R
Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
[TBL] [Abstract][Full Text] [Related]
10. What Quality Metrics Should We Apply in Barrett's Esophagus?
Desai M; Sharma P
Am J Gastroenterol; 2019 Aug; 114(8):1197-1198. PubMed ID: 31306150
[TBL] [Abstract][Full Text] [Related]
11. Quality of endoscopic surveillance of Barrett's esophagus.
Vogt JS; Larsen AC; Sommer T; Ejstrud P
Scand J Gastroenterol; 2018 Mar; 53(3):256-259. PubMed ID: 29361878
[TBL] [Abstract][Full Text] [Related]
12. An Analysis of the GIQuIC Nationwide Quality Registry Reveals Unnecessary Surveillance Endoscopies in Patients With Normal and Irregular Z-Lines.
Wani S; Williams JL; Falk GW; Komanduri S; Muthusamy VR; Shaheen NJ
Am J Gastroenterol; 2020 Nov; 115(11):1869-1878. PubMed ID: 33156106
[TBL] [Abstract][Full Text] [Related]
13. Dysplasia in Random Biopsies from Barrett's Surveillance Is an Important Marker for More Severe Pathology.
Noordzij IC; Van Loon van de Ende MCM; Curvers WL; van Lijnschoten G; Huysentruyt CJ; Schoon EJ
Dig Dis Sci; 2021 Jun; 66(6):1957-1964. PubMed ID: 32661766
[TBL] [Abstract][Full Text] [Related]
14. Real-time diagnosis of Barrett's esophagus: a prospective, multicenter study comparing confocal laser endomicroscopy with conventional histology for the identification of intestinal metaplasia in new users.
Richardson C; Colavita P; Dunst C; Bagnato J; Billing P; Birkenhagen K; Buckley F; Buitrago W; Burnette J; Leggett P; McCollister H; Stewart K; Wang T; Zfass A; Severson P
Surg Endosc; 2019 May; 33(5):1585-1591. PubMed ID: 30203202
[TBL] [Abstract][Full Text] [Related]
15. Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort.
Gaddam S; Singh M; Balasubramanian G; Thota P; Gupta N; Wani S; Higbee AD; Mathur SC; Horwhat JD; Rastogi A; Young PE; Cash BD; Bansal A; Vargo JJ; Falk GW; Lieberman DA; Sampliner RE; Sharma P
Gastroenterology; 2013 Sep; 145(3):548-53.e1. PubMed ID: 23714382
[TBL] [Abstract][Full Text] [Related]
16. Surveillance history of endoscopically treated patients with early Barrett's neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error.
Peters FP; Curvers WL; Rosmolen WD; de Vries CE; Ten Kate FJ; Krishnadath KK; Fockens P; Bergman JJ
Dis Esophagus; 2008; 21(6):475-9. PubMed ID: 18430186
[TBL] [Abstract][Full Text] [Related]
17. Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium.
Sharma P; Katzka DA; Gupta N; Ajani J; Buttar N; Chak A; Corley D; El-Serag H; Falk GW; Fitzgerald R; Goldblum J; Gress F; Ilson DH; Inadomi JM; Kuipers EJ; Lynch JP; McKeon F; Metz D; Pasricha PJ; Pech O; Peek R; Peters JH; Repici A; Seewald S; Shaheen NJ; Souza RF; Spechler SJ; Vennalaganti P; Wang K
Gastroenterology; 2015 Nov; 149(6):1599-606. PubMed ID: 26296479
[TBL] [Abstract][Full Text] [Related]
18. Image-Enhanced Endoscopy and Molecular Biomarkers Vs Seattle Protocol to Diagnose Dysplasia in Barrett's Esophagus.
Vithayathil M; Modolell I; Ortiz-Fernandez-Sordo J; Oukrif D; Pappas A; Januszewicz W; O'Donovan M; Hadjinicolaou A; Bianchi M; Blasko A; White J; Kaye P; Novelli M; Wernisch L; Ragunath K; di Pietro M
Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2514-2523.e3. PubMed ID: 35183768
[TBL] [Abstract][Full Text] [Related]
19. Barrett's esophagus surveillance in a prospective Dutch multi-center community-based cohort of 985 patients demonstrates low risk of neoplastic progression.
Klaver E; Bureo Gonzalez A; Mostafavi N; Mallant-Hent R; Duits LC; Baak B; Böhmer CJM; van Oijen AHAM; Naber T; Scholten P; Meijer SL; Bergman JJGHM; Pouw RE;
United European Gastroenterol J; 2021 Oct; 9(8):929-937. PubMed ID: 34228885
[TBL] [Abstract][Full Text] [Related]
20. Adherence to recommendations of Barrett's esophagus surveillance guidelines: a systematic review and meta-analysis.
Roumans CAM; van der Bogt RD; Steyerberg EW; Rizopoulos D; Lansdorp-Vogelaar I; Sharma P; Spaander MCW; Bruno MJ
Endoscopy; 2020 Jan; 52(1):17-28. PubMed ID: 31529444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
